(CELH) Celsius Holdings - Overview

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US15118V2079

Stock: Functional Energy Drinks, Hydration Powders, Ready-To-Drink

Total Rating 42

Risk 41

Buy Signal 0.21

Beverages - Non-Alcoholic » Soft Drinks & Non-alcoholic Beverages
Age: 19y

Market Cap: 13,529m
Avg Trading Vol: 197M USD

ATR: 4.32%
Peers RS (IBD): 81.82

EPS (Earnings per Share)

EPS CAGR: -0.90%
EPS Trend: 29.9%

Last SUE: -3.57
Qual. Beats: 0

Revenue

Rev. CAGR: 67.73%
Rev. Trend: 89.5%

Last SUE: 0.26
Qual. Beats: 0

Risk 5d forecast
Volatility	60.9%
Relative Tail Risk	-15.9%

Reward TTM
Sharpe Ratio	1.56
Alpha	111.61

Character TTM
Beta	0.845
Beta Downside	0.593

Drawdowns 3y
Max DD	77.86%
CAGR/Max DD	0.21

Description: CELH Celsius Holdings January 02, 2026

Celsius Holdings, Inc. (NASDAQ: CELH) manufactures and markets a portfolio of functional energy beverages-including CELSIUS Originals, Vibe, Essentials, On-the-Go Powder, and Hydration powders-across carbonated, non-carbonated, and ready-to-drink formats. The brand is sold through a broad channel mix: direct-to-store delivery, independent distributors, supermarkets, convenience and drug stores, specialty nutrition retailers, gyms, food-service operators, mass merchants, and e-commerce platforms.

In FY 2023 the company reported revenue of roughly $2.5 billion, a year-over-year increase of about 30%, driven by double-digit volume growth in both the U.S. and international markets. Gross margin expanded to 57% as the product mix shifted toward higher-margin powder and zero-sugar formats, while the broader non-alcoholic beverage sector benefits from sustained consumer demand for low-calorie, performance-oriented drinks and from a macro-trend toward healthier lifestyle choices.

For a deeper quantitative breakdown, the ValueRay platform provides a granular view of CELH’s financial metrics, peer benchmarks, and scenario analyses that can help sharpen your investment thesis.

Piotroski VR‑10 (Strict, 0-10) 4.0

Net Income: 64.4m TTM > 0 and > 6% of Revenue
FCF/TA: 0.10 > 0.02 and ΔFCF/TA -0.01 > 1.0
NWC/Revenue: 42.93% < 20% (prev 78.35%; Δ -35.42% < -1%)
CFO/TA 0.11 > 3% & CFO 554.6m > Net Income 64.4m
Net Debt (55.5m) to EBITDA (129.6m): 0.43 < 3
Current Ratio: 1.89 > 1.5 & < 3
Outstanding Shares: last quarter (237.2m) vs 12m ago 1.49% < -2%
Gross Margin: 51.38% > 18% (prev 0.50%; Δ 5088 % > 0.5%)
Asset Turnover: 61.00% > 50% (prev 80.43%; Δ -19.44% > 0%)
Interest Coverage Ratio: 2.94 > 6 (EBITDA TTM 129.6m / Interest Expense TTM 36.3m)

Altman Z'' 1.52

A: 0.17 (Total Current Assets 1.94b - Total Current Liabilities 1.03b) / Total Assets 5.27b
B: 0.03 (Retained Earnings 165.5m / Total Assets 5.27b)
C: 0.03 (EBIT TTM 106.7m / Avg Total Assets 3.49b)
D: 0.07 (Book Value of Equity 168.1m / Total Liabilities 2.30b)
Altman-Z'' Score: 1.52 = BB

Beneish M -0.78

DSRI: 1.58 (Receivables 513.7m/209.8m, Revenue 2.13b/1.37b)
GMI: 0.97 (GM 51.38% / 49.59%)
AQI: 3.54 (AQ_t 0.62 / AQ_t-1 0.17)
SGI: 1.55 (Revenue 2.13b / 1.37b)
TATA: -0.09 (NI 64.4m - CFO 554.6m) / TA 5.27b)
Beneish M-Score: -0.78 (Cap -4..+1) = D

What is the price of CELH shares?

As of February 09, 2026, the stock is trading at USD 50.57 with a total of 4,207,566 shares traded.
Over the past week, the price has changed by -1.46%, over one month by -1.38%, over three months by +13.49% and over the past year by +133.26%.

Is CELH a buy, sell or hold?

Celsius Holdings has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy CELH.

StrongBuy: 8
Buy: 6
Hold: 6
Sell: 1
StrongSell: 0

What are the forecasts/targets for the CELH price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	64	26.6%
Analysts Target Price	64	26.6%
ValueRay Target Price	58.4	15.4%

CELH Fundamental Data Overview February 03, 2026

P/E Trailing = 437.3333
P/E Forward = 35.8423
P/S = 6.3639
P/B = 11.4354
P/EG = 0.8694
Revenue TTM = 2.13b USD
EBIT TTM = 106.7m USD
EBITDA TTM = 129.6m USD
Long Term Debt = 861.5m USD (from longTermDebt, last quarter)
Short Term Debt = 3.37m USD (from shortTermDebt, last fiscal year)
Debt = 861.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 55.5m USD (from netDebt column, last quarter)
Enterprise Value = 13.58b USD (13.53b + Debt 861.5m - CCE 806.0m)
Interest Coverage Ratio = 2.94 (Ebit TTM 106.7m / Interest Expense TTM 36.3m)
EV/FCF = 25.94x (Enterprise Value 13.58b / FCF TTM 523.6m)
FCF Yield = 3.85% (FCF TTM 523.6m / Enterprise Value 13.58b)
FCF Margin = 24.63% (FCF TTM 523.6m / Revenue TTM 2.13b)
Net Margin = 3.03% (Net Income TTM 64.4m / Revenue TTM 2.13b)
Gross Margin = 51.38% ((Revenue TTM 2.13b - Cost of Revenue TTM 1.03b) / Revenue TTM)
Gross Margin QoQ = 51.34% (prev 51.52%)
Tobins Q-Ratio = 2.58 (Enterprise Value 13.58b / Total Assets 5.27b)
Interest Expense / Debt = 2.12% (Interest Expense 18.2m / Debt 861.5m)
Taxrate = 25.62% (50.0m / 195.1m)
NOPAT = 79.4m (EBIT 106.7m * (1 - 25.62%))
Current Ratio = 1.89 (Total Current Assets 1.94b / Total Current Liabilities 1.03b)
Debt / Equity = 0.29 (Debt 861.5m / totalStockholderEquity, last quarter 2.96b)
Debt / EBITDA = 0.43 (Net Debt 55.5m / EBITDA 129.6m)
Debt / FCF = 0.11 (Net Debt 55.5m / FCF TTM 523.6m)
Total Stockholder Equity = 1.89b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.85% (Net Income 64.4m / Total Assets 5.27b)
RoE = 3.41% (Net Income TTM 64.4m / Total Stockholder Equity 1.89b)
RoCE = 3.88% (EBIT 106.7m / Capital Employed (Equity 1.89b + L.T.Debt 861.5m))
RoIC = 6.30% (NOPAT 79.4m / Invested Capital 1.26b)
WACC = 8.58% (E(13.53b)/V(14.39b) * Re(9.03%) + D(861.5m)/V(14.39b) * Rd(2.12%) * (1-Tc(0.26)))
Discount Rate = 9.03% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 1.15%
[DCF Debug] Terminal Value 76.66% ; FCFF base≈382.0m ; Y1≈399.2m ; Y5≈461.4m
Fair Price DCF = 27.79 (EV 7.22b - Net Debt 55.5m = Equity 7.16b / Shares 257.8m; r=8.58% [WACC]; 5y FCF grow 4.81% → 2.90% )
EPS Correlation: 29.89 | EPS CAGR: -0.90% | SUE: -3.57 | # QB: 0
Revenue Correlation: 89.47 | Revenue CAGR: 67.73% | SUE: 0.26 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.28 | Chg30d=-0.000 | Revisions Net=+1 | Analysts=11
EPS next Year (2026-12-31): EPS=1.56 | Chg30d=+0.014 | Revisions Net=+1 | Growth EPS=+22.7% | Growth Revenue=+32.1%

Additional Sources for CELH Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Fund Manager Positions: Dataroma | Stockcircle